About Index Trending news
Analyze
Pricing
PolyPid

PolyPid

Work at PolyPid? Add yourself to this profile

PolyPid

PolyPid is a clinical stage emerging specialty pharmaceutical company, engaged in research and development of products based on PLEX (PolymerLipid Encapsulation MatriX), a proprietary drug delivery technology.
Edit Profile
More info

Elsewhere

Companies in the same industry

Cytovance Biologics Cytovance Biologics Emergent BioSolutions Emergent BioSolutions Prosonix Prosonix TheraVid TheraVid CEVEC Pharmaceuticals CEVEC Pharmaceuticals IDIAS-BioEnergy, LLC IDIAS-BioEnergy, LLC LYSOGENE LYSOGENE Biomatters Biomatters Inclinix Inclinix AngioChem AngioChem

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Venture capital (Series UNDISCLOSED)
$5,300,000
Venture capital (Series D)
$22,000,000
Aurum Ventures, Shavit Capital, Chaim Hurvitz
Employees

Team size

10+
Locations
HQ
Israel
Headquarters
$22,000,000 Venture capital (Series D)
FinSMEs , NoCamels

PolyPid Closes $22M Equity Financing

Health Funding
PolyPid
PolyPid